Literature DB >> 8244394

The human prohibitin (PHB) gene family and its somatic mutations in human tumors.

T Sato1, T Sakamoto, K Takita, H Saito, K Okui, Y Nakamura.   

Abstract

Five cosmid clones, isolated by procedures to screen genomic libraries for homologous variants of the human prohibitin gene (PHB), were analyzed to determine their genomic structures. Four of these (PHBP1-4) were found to be processed pseudogenes, each located on a different chromosome from their counterparts on chromosome 17q21. The DNA sequence of one clone (PHBP1, on chromosome 6q25) shared a 91.3% identity at the nucleotide level with the cDNA of functional prohibitin. A large number of human tumors of the breast, ovary, liver, and lung were examined for somatic mutations in the PHB gene. Although mutations were observed in a few sporadic breast cancers, none were identified in any of the other cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244394     DOI: 10.1006/geno.1993.1402

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  21 in total

1.  Hypothesis: Bifunctional mitochondrial proteins have centrosomal functions.

Authors:  Akilah Moore; Andy Golden
Journal:  Environ Mol Mutagen       Date:  2009-10       Impact factor: 3.216

2.  An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens.

Authors:  M M Montano; K Ekena; R Delage-Mourroux; W Chang; P Martini; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 3.  The role and therapeutic potential of prohibitin in disease.

Authors:  Arianne L Theiss; Shanthi V Sitaraman
Journal:  Biochim Biophys Acta       Date:  2011-02-04

4.  Immunohistochemical expression and mutation study of Prohibitin gene in Indian female breast cancer cases.

Authors:  Mohammad Zeeshan Najm; Shuaib Zaidi; Waseem Ahmad Siddiqui; Syed Akhtar Husain
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

5.  BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists.

Authors:  Sheng Wang; Baohua Zhang; Douglas V Faller
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

6.  Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif.

Authors:  Nick M Makridakis; Lúcio Fábio Caldas Ferraz; Juergen K V Reichardt
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

7.  Mitochondrial proteomics of nasopharyngeal carcinoma metastasis.

Authors:  Jianping Liu; Xianquan Zhan; Maoyu Li; Guoqing Li; Pengfei Zhang; Zhefeng Xiao; Meiying Shao; Fang Peng; Rong Hu; Zhuchu Chen
Journal:  BMC Med Genomics       Date:  2012-12-06       Impact factor: 3.063

8.  Genomic instability of murine hepatocellular carcinomas with low and high metastatic capacities.

Authors:  Shu-Hui Zhang; Wen-Ming Cong; Jing-Quan Shi; Hong Wei
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

9.  Prohibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses.

Authors:  Arwa S Kathiria; William L Neumann; Jennifer Rhees; Erin Hotchkiss; Yulan Cheng; Robert M Genta; Stephen J Meltzer; Rhonda F Souza; Arianne L Theiss
Journal:  Cancer Res       Date:  2012-08-06       Impact factor: 12.701

10.  Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Authors:  D Alwyn Dart; Bradley Spencer-Dene; Simon C Gamble; Jonathan Waxman; Charlotte L Bevan
Journal:  Endocr Relat Cancer       Date:  2009-07-27       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.